NTLA LONG prediction · arkinvest · Pending

Antellia Therapeutics for instance is developing a gene editing treatment uh that has shown promising clinical data and we um estimate a uh real world price of 3 million but the valuebased price could be three to four times higher than that

Channel

arkinvest

Prediction date

2026-03-13

Horizon

2027-03-13

Instrument

NTLA · LONG

Verdict

Pending

Outcome

<strong>Horizon: </strong><span data-horizon-date="2027-03-13" data-lang-zh="0">2027-03-13 · <strong>195</strong> days remaining</span>

Source: Source · 30:39 ↗